These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1649814

  • 1. Reversal of cisplatin resistance with amphotericin B in a non-small cell lung cancer cell line.
    Morikage T, Bungo M, Inomata M, Yoshida M, Ohmori T, Fujiwara Y, Nishio K, Saijo N.
    Jpn J Cancer Res; 1991 Jun; 82(6):747-51. PubMed ID: 1649814
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N.
    Cancer Res; 1993 Jul 15; 53(14):3302-7. PubMed ID: 8391922
    [Abstract] [Full Text] [Related]

  • 3. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.
    Kikkawa F, Kojima M, Oguchi H, Maeda O, Ishikawa H, Tamakoshi K, Mizuno K, Kawai M, Suganuma N, Tomoda Y.
    Anticancer Res; 1993 Jul 15; 13(4):891-6. PubMed ID: 8352556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O.
    Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells.
    Poulain L, Sichel F, Crouet H, Bureau F, Gauduchon P, Gignoux M, Le Talaër JY.
    Cancer Chemother Pharmacol; 1997 Feb 01; 40(5):385-90. PubMed ID: 9272114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
    Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T.
    Cancer Res; 1989 Sep 01; 49(17):4785-90. PubMed ID: 2547517
    [Abstract] [Full Text] [Related]

  • 12. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
    Kojima M, Kikkawa F, Oguchi H, Mizuno K, Maeda O, Tamakoshi K, Ishikawa H, Kawai M, Suganuma N, Tomoda Y.
    Eur J Cancer; 1994 Sep 01; 30A(6):773-8. PubMed ID: 7917536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Sep 01; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 17. [Modulation of cisplatin cytotoxicity by amphotericin B in six human cell lines of medullary thyroid cancer].
    Massart C, Gibassier J, Le Gall F, Raoul ML, Leclech G, Lucas C.
    Bull Cancer; 1996 Aug 01; 83(8):619-25. PubMed ID: 8869041
    [Abstract] [Full Text] [Related]

  • 18. Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells.
    Horibe S, Nagai J, Yumoto R, Tawa R, Takano M.
    J Pharm Sci; 2011 Jul 01; 100(7):3010-7. PubMed ID: 21274848
    [Abstract] [Full Text] [Related]

  • 19. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
    Heike Y, Takahashi M, Ohira T, Arioka H, Funayama Y, Nishio K, Ogasawara H, Saijo N.
    Cancer Chemother Pharmacol; 1995 Jul 01; 35(3):200-4. PubMed ID: 7805177
    [Abstract] [Full Text] [Related]

  • 20. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M, Liu X.
    Chin Med J (Engl); 1999 Apr 01; 112(4):336-9. PubMed ID: 11593534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.